GlassScriptPhysician profile
Frank Diroma
NPI 1851703748
$5,115.24
in general payments reported to CMS, 2019-2025
11 companies · $3,499 in 2025
The $3,499 reported for 2025 was more than what 87% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,308 · 2024: $308 · 2025: $3,499.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,000 · Travel and Lodging: $1,327 · Food and Beverage: $789.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,000.00 |
| Travel and Lodging | $1,326.71 |
| Food and Beverage | $788.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,365.21 | 2025 | |
| Zimmer Biomet Holdings, INC. | $1,413.20 | 2023-2025 | Ribfix Blu Advantage, Advantagerib |
| Prytime Medical Devices, INC. | $84.81 | 2024 | Er-Reboa Plus |
| Potrero Medical, INC. | $52.95 | 2023-2024 | |
| Teleflex LLC | $52.24 | 2023 | Quikclot |
| Bioventus LLC | $37.63 | 2023 | |
| Biomerieux INC | $27.00 | 2024 | Filmarray Pneumonia Panel Plus (Pneumoplus) |
| Haemonetics Corporation | $22.00 | 2024 | Teg6s Hemostasis System |
| Smith+Nephew, INC. | $21.88 | 2025 | Collagenase Santyl |
| Integra Lifesciences Corporation | $21.02 | 2023 | Duraseal Exact Spinal Sealant System, Codman Hakim, Cusa Clarity |
| Astrazeneca Pharmaceuticals LP | $17.30 | 2023 | Andexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank Diroma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.